Care must also be taken when interpreting ctDNA analysis which may not capture features such as histologic transformation, as seen in osimertinib resistance of EGFR mutant lung cancer with transformation to small-cell or squamous pathology [64, 140]. This evidence concerns the gene EGFR and lung cancer.